Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

41.58
Delayed Data
As of Aug 18
 -0.28 / -0.67%
Today’s Change
32.76
Today|||52-Week Range
43.74
+3.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line35.1M16.9M-55.6M-26.3M
 
 
 
 
 
Depreciation81.7M86.1M89.9M89.7M
 
 
 
 
 
Total Other Cash Flow21.0M19.7M114.8M97.3M
 
 
 
 
 
Funds From Operations137.6M126.8M148.1M153.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.9M-331.0K26.2M-5.8M
 
 
 
 
 
Net Cash Flow - Operating Activities139.5M127.2M121.9M159.7M
 
 
 
 
 
 
InvestingIncrease In Investments-23.1M0.000.000.00
 
 
Capital Expenditures-73.6M-122.2M-102.4M-76.1M
 
 
 
 
 
Fixed Asset Disposal488.0K452.0K637.0K2.8M
 
 
 
 
 
Net Assets From Acquisitions -9.5M0.000.000.00
 
 
Other Investing - Uses0.000.00-3.0M0.00
 
 
Net Cash Flow Investing-105.8M-121.8M-104.8M-73.3M
 
 
 
 
 
 
FinancingShort Term Borrowings-5.5M843.0K2.3M-50.7M
 
 
 
 
 
Long Term Borrowings0.00-1.0M----
 
 
Long Term Debt Reduction-38.0M-9.6M-22.3M-42.7M
 
 
 
 
 
Net Proceeds Stock Sale20.5M14.1M18.4M33.0M
 
 
 
 
 
Common Preferred Redeemed0.00-39.0M-61.0M0.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing2.4M1.6M0.000.00
 
 
 
Other Uses - Financing--0.000.000.00--
Net Cash Flow - Financing-20.7M-33.2M-62.6M-60.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash355.0K-4.1M-12.0K-1.6M
 
 
 
 
 
 
Net Change In Cash13.0M-27.8M-45.5M26.0M